Laura Marandino - Concepedia

Author

Laura Marandino

Vita-Salute San Raffaele University ORCID

Also Known As

L Marandino, L. Marandino, LAURA MARANDINO, Laura MARANDINO, Laura Marandino, Nicola PAVAN, Selcuk ERDEM, Veronica MOLLICA, Veronica Mollica

240

Publications

Citations

H-Index

Concepts

All Affiliations

Vita-Salute San Raffaele University Fondazione IRCCS Istituto Nazionale dei Tumori IRCCS Ospedale San Raffaele Istituti di Ricovero e Cura a Carattere Scientifico Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele

About

Laura Marandino is an author at Vita-Salute San Raffaele University specializing in oncology, medicine, and urology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	14	17	955
2	Health Sciences	2	2	54
3	Immunology	2	2	184
4	Geriatrics	1	1	17
5	Nephrology	1	1	17

Laura Marandino

Publications

1.5K

Citations

H-Index

Page 1

	Year	Citations
Updated Results of PURE-01 with Preliminary Activity of Neoadjuvant Pembrolizumab in Patients with Muscle-invasive Bladder Carcinoma with Variant Histologies Andrea Necchi, Daniele Raggi, Andrea Gallina, European Urology UrologyGenitourinary CancerMuscle-invasive Bladder CarcinomaMedicinePathology	2019	313
Late-onset and long-lasting immune-related adverse events from immune checkpoint-inhibitors: An overlooked aspect in immunotherapy Eleonora Ghisoni, Alexandre Wicky, Hasna Bouchaab, European Journal of Cancer	2021	180
Impact of Molecular Subtyping and Immune Infiltration on Pathological Response and Outcome Following Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer Andrea Necchi, Daniele Raggi, Andrea Gallina, European Urology Molecular SubtypingUrologyGenitourinary CancerMedicineImmunology	2020	172
Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer: Preliminary Findings from the PURE-01 Study Andrea Necchi, Marco Bandini, Giuseppina Calareso, European Urology Tumor ResponseUrologyOncologic ImagingGenitourinary CancerMedicine	2019	106
Neoadjuvant Pembrolizumab and Radical Cystectomy in Patients with Muscle-Invasive Urothelial Bladder Cancer: 3-Year Median Follow-Up Update of PURE-01 Trial Giuseppe Basile, Marco Bandini, Ewan A. Gibb, Clinical Cancer Research	2022	101
Does the administration of preoperative pembrolizumab lead to sustained remission post-cystectomy? First survival outcomes from the PURE-01 study☆ Marco Bandini, Ewan A. Gibb, Andrea Gallina, Annals of Oncology	2020	82
Expression-based subtypes define pathologic response to neoadjuvant immune-checkpoint inhibitors in muscle-invasive bladder cancer A. Gordon Robertson, Khyati Meghani, Lauren Folgosa Cooley, Nature Communications	2023	58
Is There a Detrimental Effect of Antibiotic Therapy in Patients with Muscle-invasive Bladder Cancer Treated with Neoadjuvant Pembrolizumab? Filippo Pederzoli, Marco Bandini, Daniele Raggi, European Urology UrologyAntibioticsGenitourinary CancerMedicineAntibiotic Adjuvant	2021	50
Association Between Human Papillomavirus Infection and Outcome of Perioperative Nodal Radiotherapy for Penile Carcinoma Marco Bandini, Jeffrey S. Ross, Yao Zhu, European Urology Oncology Penile CarcinomaCervical CancerMedicinePerioperative Nodal RadiotherapyPathology	2020	48
Predicting the Pathologic Complete Response After Neoadjuvant Pembrolizumab in Muscle-Invasive Bladder Cancer Marco Bandini, Jeffrey S. Ross, Daniele Raggi, JNCI Journal of the National Cancer Institute	2020	42

Page 1